BR100 Decreased By (-1.5%)
BR30 Decreased By (-1.91%)
KSE100 Decreased By (-1.24%)
KSE30 Decreased By (-1.28%)
AGHA 7.89 Decreased By ▼ -0.11 (-1.38%)
BECO 5.39 Decreased By ▼ -0.03 (-0.55%)
BML 64.15 Decreased By ▼ -1.46 (-2.23%)
BOP 35.45 Decreased By ▼ -0.65 (-1.8%)
CNERGY 9.81 Increased By ▲ 0.12 (1.24%)
CSIL 5.90 Decreased By ▼ -0.05 (-0.84%)
FCCL 54.54 Decreased By ▼ -1.34 (-2.4%)
FFL 17.35 Decreased By ▼ -0.23 (-1.31%)
FNEL 1.23 Decreased By ▼ -0.02 (-1.6%)
KEL 7.96 Decreased By ▼ -0.14 (-1.73%)
KOSM 5.93 Decreased By ▼ -0.20 (-3.26%)
LOTCHEM 31.33 Decreased By ▼ -0.13 (-0.41%)
MLCF 102.09 Decreased By ▼ -2.15 (-2.06%)
NBP 206.50 Decreased By ▼ -4.07 (-1.93%)
NCPL 59.07 Decreased By ▼ -1.09 (-1.81%)
NPL 66.90 Decreased By ▼ -1.59 (-2.32%)
OGDC 331.70 Decreased By ▼ -2.43 (-0.73%)
PACE 11.34 Decreased By ▼ -0.22 (-1.9%)
PAEL 43.90 Decreased By ▼ -1.13 (-2.51%)
PIBTL 17.70 Decreased By ▼ -0.27 (-1.5%)
PPL 233.00 Decreased By ▼ -3.55 (-1.5%)
PRL 43.36 Increased By ▲ 1.29 (3.07%)
PTC 69.10 Decreased By ▼ -1.89 (-2.66%)
SSGC 30.20 Decreased By ▼ -0.63 (-2.04%)
TBL 10.55 Decreased By ▼ -0.01 (-0.09%)
TELE 9.08 Decreased By ▼ -0.09 (-0.98%)
TPL 17.10 Decreased By ▼ -0.37 (-2.12%)
TPLP 12.15 Decreased By ▼ -0.47 (-3.72%)
TREET 24.32 Decreased By ▼ -0.41 (-1.66%)
TRG 64.90 Decreased By ▼ -0.68 (-1.04%)
Pakistan

Interior Minister Ijaz Shah gets first dose of COVID-19 trial vaccine

  • UHS Vice-Chancellor Prof Javed Akram says the minister’s staff members were also administered the trial vaccine
  • China had supplied the medication, developed by Chinese biotech CanSinoBio in partnership with the Beijing Institute of Biotechnology, to Islamabad as part of a trial agreement
Published Updated

(Karachi) Federal Interior Minister Ijaz Shah has been administered trial vaccine of COVID-19 from China at the University of Health Sciences (UHS) Lahore, local media reported on Monday.

“Interior Minister Ijaz Shah was administered the vaccine, which has been in phase three of clinical trials,” UHS Vice-Chancellor Prof Dr Javed Akram said.

“The minister’s staff members were also administered the trial vaccine,” Prof Akram added.

Earlier, Pakistan began final-phase testing of a Chinese-made vaccine against novel coronavirus, the first ever clinical trial of its kind in the South Asian nation.

China had supplied the COVID-19 medication, developed by Chinese biotech CanSinoBio in partnership with the Beijing Institute of Biotechnology, to Islamabad as part of a trial agreement.

So far, the trial vaccine has seen a positive public response, raising the hope that the effort would meet its target. The specific vaccine has already established its safety and efficacy in the previous trials held in China with no serious adverse effects.

It’s now being tested on a wider population in Russia, Mexico, Chile, Argentina, Saudi Arabia and Pakistan; the country has been allocated 8,000 recruits out of a total of 40,000 and is currently conducting the trial at five centres in Islamabad, Lahore and Karachi.

Comments

Comments are closed for this article.